↓ Skip to main content

Dove Medical Press

Article Metrics

Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, March 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
23 Mendeley
Title
Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid
Published in
Clinical Pharmacology : Advances and Applications, March 2012
DOI 10.2147/cpaa.s25784
Pubmed ID
Authors

Justin Gandy

Abstract

The purpose of this research was to determine the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid (CHD-FA).

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 22%
Researcher 4 17%
Student > Postgraduate 3 13%
Student > Ph. D. Student 1 4%
Professor 1 4%
Other 3 13%
Unknown 6 26%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 26%
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Medicine and Dentistry 2 9%
Nursing and Health Professions 1 4%
Mathematics 1 4%
Other 2 9%
Unknown 7 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2012.
All research outputs
#2,325,425
of 4,506,407 outputs
Outputs from Clinical Pharmacology : Advances and Applications
#44
of 69 outputs
Outputs of similar age
#35,397
of 75,175 outputs
Outputs of similar age from Clinical Pharmacology : Advances and Applications
#2
of 4 outputs
Altmetric has tracked 4,506,407 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 69 research outputs from this source. They receive a mean Attention Score of 1.9. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 75,175 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.